Evidence map›Paper›PMID 28479854›Full record

ArticleInternational journal of nanomedicine2017

Mn

Juqun Xi, Lanyue Da, Changshui Yang, Rui Chen, Lizeng Gao, Lei Fan, Jie Han

Abstract read
In one paragraph

Article in International journal of nanomedicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Synthesis of FeFrontiers in bioengineering and biotechnology · 2022
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Juqun XiPharmacology Department, Medical School, Yangzhou University.
Lanyue DaPharmacology Department, Medical School, Yangzhou University.
Changshui YangPharmacology Department, Medical School, Yangzhou University.
Rui ChenDepartment of Nephrology, Subei People's Hospital, Yangzhou University.
Lizeng GaoJiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases.
Lei FanSchool of Chemistry and Chemical Engineering, Yangzhou University, Yangzhou, Jiangsu, People's Republic of China.
Jie HanSchool of Chemistry and Chemical Engineering, Yangzhou University, Yangzhou, Jiangsu, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanoparticle drug delivery carriers, which can implement high performances of multi-functions, are of great interest, especially for improving cancer therapy. Herein, we reported a new approach to construct Mn

Indexed as

AnimalsAntibiotics, AntineoplasticCell LineDoxorubicinDrug CarriersDrug Delivery SystemsDrug LiberationFemaleHydrogen-Ion ConcentrationIndolesLactic AcidMagnetic Resonance ImagingManganeseMice, Inbred BALB CNanoparticlesNeoplasmsAntibiotics, AntineoplasticDoxorubicinDrug CarriersIndolesLactic AcidManganesepolydopaminePolyglycolic AcidPolylactic Acid-Polyglycolic Acid CopolymerPolymerschemo-photothermal therapyPLGA nanoparticlespolydopaminesmart theranostic agent

Identifiers

PMID28479854
PMCPMC5411169

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.